Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2011

Open Access 01-12-2011 | Review

Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa

Authors: Richard G Wamai, Brian J Morris, Stefan A Bailis, David Sokal, Jeffrey D Klausner, Ross Appleton, Nelson Sewankambo, David A Cooper, John Bongaarts, Guy de Bruyn, Alex D Wodak, Joya Banerjee

Published in: Journal of the International AIDS Society | Issue 1/2011

Login to get access

Abstract

Heterosexual exposure accounts for most HIV transmission in sub-Saharan Africa, and this mode, as a proportion of new infections, is escalating globally. The scientific evidence accumulated over more than 20 years shows that among the strategies advocated during this period for HIV prevention, male circumcision is one of, if not, the most efficacious epidemiologically, as well as cost-wise. Despite this, and recommendation of the procedure by global policy makers, national implementation has been slow. Additionally, some are not convinced of the protective effect of male circumcision and there are also reports, unsupported by evidence, that non-sex-related drivers play a major role in HIV transmission in sub-Saharan Africa. Here, we provide a critical evaluation of the state of the current evidence for male circumcision in reducing HIV infection in light of established transmission drivers, provide an update on programmes now in place in this region, and explain why policies based on established scientific evidence should be prioritized. We conclude that the evidence supports the need to accelerate the implementation of medical male circumcision programmes for HIV prevention in generalized heterosexual epidemics, as well as in countering the growing heterosexual transmission in countries where HIV prevalence is presently low.
Literature
1.
go back to reference Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005, 2:1112–1122.CrossRef Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med 2005, 2:1112–1122.CrossRef
2.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007, 369:643–646.PubMedCrossRef Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 2007, 369:643–646.PubMedCrossRef
3.
go back to reference Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 2007, 369:657–666.PubMedCrossRef Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 2007, 369:657–666.PubMedCrossRef
4.
go back to reference Siegfried N, Muller M, Volmink J, Deeks JJ, Egger M, Low N, Weiss H, Walker S, Williamson P: Male circumcision for prevention of heterosexual acquisition of HIV in men (Review). Cochrane Database of Syst Rev 2009, 2:CD003362. Siegfried N, Muller M, Volmink J, Deeks JJ, Egger M, Low N, Weiss H, Walker S, Williamson P: Male circumcision for prevention of heterosexual acquisition of HIV in men (Review). Cochrane Database of Syst Rev 2009, 2:CD003362.
5.
go back to reference Lie RK, Miller FG: What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection. BMC Med Res Methodol 2011, 11:34.PubMedCrossRef Lie RK, Miller FG: What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection. BMC Med Res Methodol 2011, 11:34.PubMedCrossRef
6.
go back to reference Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA: Male circumcision for HIV prevention: from evidence to action? AIDS 2008, 22:567–574.PubMedCrossRef Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA: Male circumcision for HIV prevention: from evidence to action? AIDS 2008, 22:567–574.PubMedCrossRef
7.
go back to reference Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000, 14:2361–2370.PubMedCrossRef Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000, 14:2361–2370.PubMedCrossRef
8.
go back to reference Mills E, Cooper C, Anema A, Guyatt A: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008, 9:332–335.PubMedCrossRef Mills E, Cooper C, Anema A, Guyatt A: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008, 9:332–335.PubMedCrossRef
9.
go back to reference Byakika-Tusiime J: Circumcision and HIV infection: assessment of causality. AIDS Behav 2008, 12:835–841.PubMedCrossRef Byakika-Tusiime J: Circumcision and HIV infection: assessment of causality. AIDS Behav 2008, 12:835–841.PubMedCrossRef
10.
go back to reference Hill BA: The environment and disease: Association or causation? Proc Royal Soc Med 1965, 58:295–300. Hill BA: The environment and disease: Association or causation? Proc Royal Soc Med 1965, 58:295–300.
14.
go back to reference Ministry of Health, National AIDS and STD Control Program: National Guidance for Voluntary Male Circumcision in Kenya. Nairobi; 2008. Ministry of Health, National AIDS and STD Control Program: National Guidance for Voluntary Male Circumcision in Kenya. Nairobi; 2008.
16.
go back to reference Rotheram-Borus MJ, Swendeman D, Chovnick G: The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol 2009, 5:143–167.PubMedCrossRef Rotheram-Borus MJ, Swendeman D, Chovnick G: The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol 2009, 5:143–167.PubMedCrossRef
20.
go back to reference Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M: Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr 2008,49(4):410–415.PubMedCrossRef Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M: Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr 2008,49(4):410–415.PubMedCrossRef
21.
go back to reference Gisselquist D, Potterat JJ, St Lawrence JS, Hogan M, Arora NK, Correa M, Dinsmore WW, Mehta G, Millogo J, Muth SQ, Okinyi M, Ounga T: How to contain generalized HIV epidemics? A plea for better evidence to displace speculation. Int J STD AIDS 2009, 20:443–446.PubMedCrossRef Gisselquist D, Potterat JJ, St Lawrence JS, Hogan M, Arora NK, Correa M, Dinsmore WW, Mehta G, Millogo J, Muth SQ, Okinyi M, Ounga T: How to contain generalized HIV epidemics? A plea for better evidence to displace speculation. Int J STD AIDS 2009, 20:443–446.PubMedCrossRef
23.
go back to reference Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N: Sexual behavior in co ntext: A global perspective. Lancet 2006, 368:1706–1728.PubMedCrossRef Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N: Sexual behavior in co ntext: A global perspective. Lancet 2006, 368:1706–1728.PubMedCrossRef
24.
go back to reference Baggaley RF, Fraser C: Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS 2010, 5:269–276.PubMedCrossRef Baggaley RF, Fraser C: Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS 2010, 5:269–276.PubMedCrossRef
26.
go back to reference Miller WC: Role of acute and early HIV infection in the sexual transmission of HIV. Current Opinion in HIV & AIDS 2010, 5:277–282.CrossRef Miller WC: Role of acute and early HIV infection in the sexual transmission of HIV. Current Opinion in HIV & AIDS 2010, 5:277–282.CrossRef
27.
go back to reference Robinson NJ, Mulder DW, Auvert B, Hayes RJ: Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS 1995, 9:1263–1270.PubMedCrossRef Robinson NJ, Mulder DW, Auvert B, Hayes RJ: Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS 1995, 9:1263–1270.PubMedCrossRef
28.
go back to reference Leclerc PM, Matthews AP, Garenne ML: Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One 2009, 4:e5439.PubMedCrossRef Leclerc PM, Matthews AP, Garenne ML: Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One 2009, 4:e5439.PubMedCrossRef
32.
go back to reference Brown T, Bao L, Raftery AE, Solomon JA, Baggaley RF, Stover J, Gerland P: Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. STI Supplement 2010,86(Suppl 2):ii3e10. Brown T, Bao L, Raftery AE, Solomon JA, Baggaley RF, Stover J, Gerland P: Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. STI Supplement 2010,86(Suppl 2):ii3e10.
33.
go back to reference Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus IM: The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect 2010,86(Suppl 2):ii16e21.CrossRef Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus IM: The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect 2010,86(Suppl 2):ii16e21.CrossRef
34.
go back to reference Ghys P, Garnett GP: The 2009 HIV and AIDS estimates and projections: methods, tools and analyses. Sex Transm Infect 2010, 86:ii1-ii2.CrossRef Ghys P, Garnett GP: The 2009 HIV and AIDS estimates and projections: methods, tools and analyses. Sex Transm Infect 2010, 86:ii1-ii2.CrossRef
36.
go back to reference Varghese B, Maher JE, Peterman TA, Branson BM, Stekette RW: Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002, 29:38–43.PubMedCrossRef Varghese B, Maher JE, Peterman TA, Branson BM, Stekette RW: Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002, 29:38–43.PubMedCrossRef
37.
go back to reference Boily M-C, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M: Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009, 9:118–129.PubMedCrossRef Boily M-C, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M: Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009, 9:118–129.PubMedCrossRef
38.
go back to reference Orroth KK, White RG, Freeman EE, Bakker R, Buvé A, Glynn JR, Dik F Habbema J, Hayes RJ: Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of. Sex Transm Infect 2011, in press. Orroth KK, White RG, Freeman EE, Bakker R, Buvé A, Glynn JR, Dik F Habbema J, Hayes RJ: Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of. Sex Transm Infect 2011, in press.
40.
go back to reference Sousa JD, Muller V, Lemey P, Vandamme AM: High GUD incidence in the early 20th century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS ONE 2010, 5:e9936.PubMedCrossRef Sousa JD, Muller V, Lemey P, Vandamme AM: High GUD incidence in the early 20th century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS ONE 2010, 5:e9936.PubMedCrossRef
41.
go back to reference Parkhurst JO: Understanding the correlations between wealth, poverty and human immunodeficiency virus infection in African countries. Bull World Health Organ 2010, 88:481–560.CrossRef Parkhurst JO: Understanding the correlations between wealth, poverty and human immunodeficiency virus infection in African countries. Bull World Health Organ 2010, 88:481–560.CrossRef
42.
go back to reference Auvert B, Buvé A, Ferry B, Caraël M, Morison L, Lagarde E, Robinson NJ, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Study Group on the Heterogeneity of HIV Epidemics in African Cities: Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001,15(Suppl):S15-S30.PubMedCrossRef Auvert B, Buvé A, Ferry B, Caraël M, Morison L, Lagarde E, Robinson NJ, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Study Group on the Heterogeneity of HIV Epidemics in African Cities: Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001,15(Suppl):S15-S30.PubMedCrossRef
43.
go back to reference Buve A: The HIV epidemics in sub-Saharan Africa: why so severe? Why so heterogenous? An epidemiological perspective. In The HIV/AIDS Epidemic in Sub-Saharan Africa in a Historical Perspective. Edited by: Denis P, Becker C. Senegalese Network "Law, Ethics, Health"; 2006:41–55. Buve A: The HIV epidemics in sub-Saharan Africa: why so severe? Why so heterogenous? An epidemiological perspective. In The HIV/AIDS Epidemic in Sub-Saharan Africa in a Historical Perspective. Edited by: Denis P, Becker C. Senegalese Network "Law, Ethics, Health"; 2006:41–55.
44.
go back to reference Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, Auvert B: Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009, 199:958–964.PubMedCrossRef Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, Auvert B: Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis 2009, 199:958–964.PubMedCrossRef
45.
go back to reference Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, Anagonou S, Kanhonou L, Laourou M, Abega S, Akam E, Zekeng L, Chege J, Kahindo M, Rutenberg N, Kaona F, Musonda R, Sukwa T, Morison L, Weiss HA, Laga M, Study Group on Heterogeneity of HIV Epidemics in African Cities: Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS 2001,15(Suppl 4):S5-S14.PubMedCrossRef Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, Anagonou S, Kanhonou L, Laourou M, Abega S, Akam E, Zekeng L, Chege J, Kahindo M, Rutenberg N, Kaona F, Musonda R, Sukwa T, Morison L, Weiss HA, Laga M, Study Group on Heterogeneity of HIV Epidemics in African Cities: Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS 2001,15(Suppl 4):S5-S14.PubMedCrossRef
46.
go back to reference Halperin D, Epstein H: Concurrent sexual partnerships help explain Africa's high HIV prevalence: implications for prevention. Lancet 2004, 364:4–6.PubMedCrossRef Halperin D, Epstein H: Concurrent sexual partnerships help explain Africa's high HIV prevalence: implications for prevention. Lancet 2004, 364:4–6.PubMedCrossRef
47.
go back to reference Shelton JD: Why multiple sexual partners? Lancet 2009, 374–367. Shelton JD: Why multiple sexual partners? Lancet 2009, 374–367.
48.
go back to reference Morris M: Barking up the wrong evidence tree. Comment on Lurie & Rosenthal, ''Concurrent partnerships as a driver of the HIV epidemic in Sub-Saharan Africa? The evidence is limited". AIDS Behav 2010, 14:31–33.PubMedCrossRef Morris M: Barking up the wrong evidence tree. Comment on Lurie & Rosenthal, ''Concurrent partnerships as a driver of the HIV epidemic in Sub-Saharan Africa? The evidence is limited". AIDS Behav 2010, 14:31–33.PubMedCrossRef
50.
go back to reference Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N: Sexual behavior in context: A global perspective. Lancet 2006, 368:1706–1728.PubMedCrossRef Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, Bajos N: Sexual behavior in context: A global perspective. Lancet 2006, 368:1706–1728.PubMedCrossRef
51.
go back to reference Reniers G, Tfaily R: Polygyny and HIV in Malawi. Demographic Resh 2008, 19:1811–1830.CrossRef Reniers G, Tfaily R: Polygyny and HIV in Malawi. Demographic Resh 2008, 19:1811–1830.CrossRef
53.
go back to reference Watts CH, May RM: The influence of concurrent partnerships on the dynamics of HIV/AIDS. Mathematical Biosciences 1992, 108:89–104.PubMedCrossRef Watts CH, May RM: The influence of concurrent partnerships on the dynamics of HIV/AIDS. Mathematical Biosciences 1992, 108:89–104.PubMedCrossRef
54.
go back to reference Morris M, Kretzschmar M: Concurrent partnerships and transmission dynamics in networks. Social Networks 1995, 17:299–318.CrossRef Morris M, Kretzschmar M: Concurrent partnerships and transmission dynamics in networks. Social Networks 1995, 17:299–318.CrossRef
55.
go back to reference Lurie MN, Rosenthal S: Concurrent partnerships as a driver of the HIV epidemic in sub-saharan Africa? The evidence is limited. AIDS Behav 2010, 14:17–24.PubMedCrossRef Lurie MN, Rosenthal S: Concurrent partnerships as a driver of the HIV epidemic in sub-saharan Africa? The evidence is limited. AIDS Behav 2010, 14:17–24.PubMedCrossRef
56.
go back to reference Sawers L, Stillwaggon E: Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J Int AIDS Soc 2010, 13:34.PubMedCrossRef Sawers L, Stillwaggon E: Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J Int AIDS Soc 2010, 13:34.PubMedCrossRef
58.
go back to reference Chin J, Sato PA, Mann JM: Projections of HIV infections and AIDS cases to the year 2000. Bull World Health Organ 1990, 68:1–11.PubMed Chin J, Sato PA, Mann JM: Projections of HIV infections and AIDS cases to the year 2000. Bull World Health Organ 1990, 68:1–11.PubMed
59.
go back to reference Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M: Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999, 77:789–800.PubMed Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M: Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999, 77:789–800.PubMed
60.
go back to reference Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP, 2007 Reference Group to the UN on HIV and Injecting Drug Use: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733–1745.PubMedCrossRef Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP, 2007 Reference Group to the UN on HIV and Injecting Drug Use: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733–1745.PubMedCrossRef
61.
go back to reference Gouws E, White PJ, Stover J, Brown T: Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 2006,82(Suppl 3):iii51-iii55.PubMedCrossRef Gouws E, White PJ, Stover J, Brown T: Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 2006,82(Suppl 3):iii51-iii55.PubMedCrossRef
64.
go back to reference Mahy M, Kiragu K, Hayashi C, Akwara P, Luo C, Stanecki K, Ekpini R, Shaffer N: What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010, 86:ii48-ii55.PubMedCrossRef Mahy M, Kiragu K, Hayashi C, Akwara P, Luo C, Stanecki K, Ekpini R, Shaffer N: What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010, 86:ii48-ii55.PubMedCrossRef
65.
go back to reference Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW: Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet 2009, 374:416–422.PubMedCrossRef Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW: Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet 2009, 374:416–422.PubMedCrossRef
66.
go back to reference Baral S, Sifakis F, Cleghorn F, Beyrer C: Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: A systematic review. PLoS Med 2007, 4:e339.PubMedCrossRef Baral S, Sifakis F, Cleghorn F, Beyrer C: Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: A systematic review. PLoS Med 2007, 4:e339.PubMedCrossRef
67.
go back to reference Hrdy DB: Cultural practices contributing to transmission of human immunodeficiency virus in Africa. Rev Infect Dis 1987, 9:1109–1119.PubMedCrossRef Hrdy DB: Cultural practices contributing to transmission of human immunodeficiency virus in Africa. Rev Infect Dis 1987, 9:1109–1119.PubMedCrossRef
68.
go back to reference Ounga T, Okinyi M, Onyuro S, Correa M, Gisselquist D: Exploratory study of blood exposures that are risks for HIV among Luo and Kisii ethnic groups in Nyanza province, Kenya. Int J STD AIDS 2009, 20:19–23.PubMedCrossRef Ounga T, Okinyi M, Onyuro S, Correa M, Gisselquist D: Exploratory study of blood exposures that are risks for HIV among Luo and Kisii ethnic groups in Nyanza province, Kenya. Int J STD AIDS 2009, 20:19–23.PubMedCrossRef
71.
go back to reference Bailey RC, Egesah O, Rosenberg S: Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ 2008, 86:669–677.PubMedCrossRef Bailey RC, Egesah O, Rosenberg S: Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ 2008, 86:669–677.PubMedCrossRef
72.
go back to reference Wilcken A, Keil T, Dick B: Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bull World Health Organ 2010, 88:907–914.PubMedCrossRef Wilcken A, Keil T, Dick B: Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bull World Health Organ 2010, 88:907–914.PubMedCrossRef
73.
go back to reference Apetrei C, Becker J, Metzger M, Gautam R, Engle J, Wales AK, Eyong M, Enyong P, Sama M, Foley BT, Drucker E, Marx PA: Potential for HIV transmission through unsafe injections. AIDS 2006, 20:1074–1076.PubMedCrossRef Apetrei C, Becker J, Metzger M, Gautam R, Engle J, Wales AK, Eyong M, Enyong P, Sama M, Foley BT, Drucker E, Marx PA: Potential for HIV transmission through unsafe injections. AIDS 2006, 20:1074–1076.PubMedCrossRef
74.
go back to reference Reid SR: Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J 2009, 6:24.PubMedCrossRef Reid SR: Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J 2009, 6:24.PubMedCrossRef
75.
go back to reference Hiemstra R, Rabie H, Schaaf HS, Eley B, Cameron N, Mehtar S, Janse van Rensburg A, Cotton MF: Unexplained HIV-1 infection in children -- documenting cases and assessing for possible risk factors. S Afr Med J 2004, 94:188–193.PubMed Hiemstra R, Rabie H, Schaaf HS, Eley B, Cameron N, Mehtar S, Janse van Rensburg A, Cotton MF: Unexplained HIV-1 infection in children -- documenting cases and assessing for possible risk factors. S Afr Med J 2004, 94:188–193.PubMed
76.
go back to reference Schmid GP, Buvé A, Mugyenyi P, Garnett GP, Hayes RJ, Williams BG, Calleja JG, De Cock KM, Whitworth JA, Kapiga SH, Ghys PD, Hankins C, Zaba B, Heimer R, Boerma JT: Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004, 363:482–488.PubMedCrossRef Schmid GP, Buvé A, Mugyenyi P, Garnett GP, Hayes RJ, Williams BG, Calleja JG, De Cock KM, Whitworth JA, Kapiga SH, Ghys PD, Hankins C, Zaba B, Heimer R, Boerma JT: Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004, 363:482–488.PubMedCrossRef
77.
go back to reference de Walque D: Do unsafe tetanus toxoid injections play a significant role in the transmission of HIV/AIDS? Evidence from seven African countries. Sex Transm Infect 2008, 84:122–125.PubMedCrossRef de Walque D: Do unsafe tetanus toxoid injections play a significant role in the transmission of HIV/AIDS? Evidence from seven African countries. Sex Transm Infect 2008, 84:122–125.PubMedCrossRef
78.
go back to reference Khobotlo M, Tshehlo R, Nkonyana J, Ramoseme M, Khobotle M, Chitoshia A, Hildebrand M, Fraser N: Lesotho: HIV prevention response and modes of transmission analysis. Maseru: Lesotho National AIDS Commission; 2009. Khobotlo M, Tshehlo R, Nkonyana J, Ramoseme M, Khobotle M, Chitoshia A, Hildebrand M, Fraser N: Lesotho: HIV prevention response and modes of transmission analysis. Maseru: Lesotho National AIDS Commission; 2009.
79.
go back to reference Mngadi S, Fraser N, Mkhatshwa H, Lapidos P, Khumalo T, Tsela S, Nhlabatsi N, Odido H: Swaziland: HIV prevention response and modes of transmission analysis. Mbabane, National Emergency Response Council on HIV/AIDS; 2009. Mngadi S, Fraser N, Mkhatshwa H, Lapidos P, Khumalo T, Tsela S, Nhlabatsi N, Odido H: Swaziland: HIV prevention response and modes of transmission analysis. Mbabane, National Emergency Response Council on HIV/AIDS; 2009.
80.
go back to reference Wabwire-Mangen F, Odiit M, Kirungi W, Kisitu DK, Wanyama JO: Uganda: HIV modes of transmission and prevention response analysis. Kampala: Uganda National AIDS Commission; 2009. Wabwire-Mangen F, Odiit M, Kirungi W, Kisitu DK, Wanyama JO: Uganda: HIV modes of transmission and prevention response analysis. Kampala: Uganda National AIDS Commission; 2009.
81.
go back to reference Mulenga O, Witola H, Buyu C, Gboun M, Sunkutu MR, Rodriguez-Garcia R, Gorgens M, Fraser-Hurt N, Sattin E, Potter D, Dzekedzeke K, Banda R, Michelo C: Zambia: HIV prevention response and modes of transmission analysis. Lusaka: Zambia National HIV/AIDS/STI/TB Council;; 2009. Mulenga O, Witola H, Buyu C, Gboun M, Sunkutu MR, Rodriguez-Garcia R, Gorgens M, Fraser-Hurt N, Sattin E, Potter D, Dzekedzeke K, Banda R, Michelo C: Zambia: HIV prevention response and modes of transmission analysis. Lusaka: Zambia National HIV/AIDS/STI/TB Council;; 2009.
82.
go back to reference Baral S, Dausab F, Masenior N, Iipinge S, Beyrer C: A Systematic Review of HIV epidemiology and risk factors among MSM in Sub-Saharan Africa 2000–2008. XVII International AIDS Conference, Mexico City; 2008. Baral S, Dausab F, Masenior N, Iipinge S, Beyrer C: A Systematic Review of HIV epidemiology and risk factors among MSM in Sub-Saharan Africa 2000–2008. XVII International AIDS Conference, Mexico City; 2008.
83.
go back to reference Sanders EJ, Graham SM, Okuku HS, van der Elst EM, Muhaari A, Davies A, Peshu N, Price M, McClelland : HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya. AIDS 2007, 21:2513–2520.PubMedCrossRef Sanders EJ, Graham SM, Okuku HS, van der Elst EM, Muhaari A, Davies A, Peshu N, Price M, McClelland : HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya. AIDS 2007, 21:2513–2520.PubMedCrossRef
84.
go back to reference Brody S, Potterat JJ: Establishing valid AIDS monitoring and research in countries with generalized epidemics. Int J STD AIDS 2004, 15:1–6.PubMedCrossRef Brody S, Potterat JJ: Establishing valid AIDS monitoring and research in countries with generalized epidemics. Int J STD AIDS 2004, 15:1–6.PubMedCrossRef
85.
go back to reference Lagarde E, Caraël M, Auvert B, Buve A: Concurrency and sexual transmission: a response to the letter by Rothenberg et al. AIDS 2002, 16:679–680.CrossRef Lagarde E, Caraël M, Auvert B, Buve A: Concurrency and sexual transmission: a response to the letter by Rothenberg et al. AIDS 2002, 16:679–680.CrossRef
86.
go back to reference Kaicher DC, Swan KG: A Cut Above: Circumcision as an ancient status symbol. Urology 2010, 76:18–20.PubMedCrossRef Kaicher DC, Swan KG: A Cut Above: Circumcision as an ancient status symbol. Urology 2010, 76:18–20.PubMedCrossRef
87.
go back to reference Morris BJ: Why circumcision is a biomedical imperative for the 21st century. BioEssays 2007, 29:1147–1158.PubMedCrossRef Morris BJ: Why circumcision is a biomedical imperative for the 21st century. BioEssays 2007, 29:1147–1158.PubMedCrossRef
88.
go back to reference Gollaher D: A History of the World's Most Controversial Surgery. New York; 2000. Gollaher D: A History of the World's Most Controversial Surgery. New York; 2000.
89.
go back to reference Alcena V: AIDS in third world countries. New York State J Med 1986, 86:446. Alcena V: AIDS in third world countries. New York State J Med 1986, 86:446.
90.
go back to reference Fink AJ: A possible explanation for heterosexual male infection with AIDS. N Engl J Med 1986, 315:1167.PubMed Fink AJ: A possible explanation for heterosexual male infection with AIDS. N Engl J Med 1986, 315:1167.PubMed
91.
go back to reference Bongaarts J, Reining P, Way P, Conant F: The relationship between male circumcision and HIV infection in African populations. AIDS 1989, 3:373–377.PubMedCrossRef Bongaarts J, Reining P, Way P, Conant F: The relationship between male circumcision and HIV infection in African populations. AIDS 1989, 3:373–377.PubMedCrossRef
92.
go back to reference Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 2000, 14:2371–2381.PubMedCrossRef Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 2000, 14:2371–2381.PubMedCrossRef
93.
go back to reference Siegfried N, Muller M, Deeks J, Volmink J, Egger M, Low N, Walker S, Williamson P: HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis 2005, 5:165–173.PubMed Siegfried N, Muller M, Deeks J, Volmink J, Egger M, Low N, Walker S, Williamson P: HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis 2005, 5:165–173.PubMed
94.
go back to reference Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC: Male circumcision, religion and infectious diseases: An ecologic analysis of 118 developing countries. BMC Infect Dis 2006, 6:172.PubMedCrossRef Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC: Male circumcision, religion and infectious diseases: An ecologic analysis of 118 developing countries. BMC Infect Dis 2006, 6:172.PubMedCrossRef
95.
go back to reference Padian NS, McCoy SI, Balkus JE, Wasserheit JN: Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621–635.PubMedCrossRef Padian NS, McCoy SI, Balkus JE, Wasserheit JN: Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621–635.PubMedCrossRef
97.
go back to reference Westercamp N, Bailey RC: Acceptability of Male Circumcision for Prevention of HIV/AIDS in Sub-Saharan Africa: A Review. AIDS Behav 2007, 11:341–355.PubMedCrossRef Westercamp N, Bailey RC: Acceptability of Male Circumcision for Prevention of HIV/AIDS in Sub-Saharan Africa: A Review. AIDS Behav 2007, 11:341–355.PubMedCrossRef
98.
go back to reference Bailey RC: Acceptability of male circumcision for prevention of HIV infection in Zambia. AIDS Care 2007, 19:471–477.PubMedCrossRef Bailey RC: Acceptability of male circumcision for prevention of HIV infection in Zambia. AIDS Care 2007, 19:471–477.PubMedCrossRef
99.
go back to reference Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med 2006, 3:e262.PubMedCrossRef Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B: The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med 2006, 3:e262.PubMedCrossRef
100.
go back to reference Sawires SR, Dworkin SL Fiamma A, Peacock D, Szekeres G, Coates TJ: Male circumcision and HIV/AIDS: challenges and opportunities. Lancet 2007, 369:708–713.PubMedCrossRef Sawires SR, Dworkin SL Fiamma A, Peacock D, Szekeres G, Coates TJ: Male circumcision and HIV/AIDS: challenges and opportunities. Lancet 2007, 369:708–713.PubMedCrossRef
101.
go back to reference De Bruyn G, Martinson N, Gray GE: Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Rev Anti Infect Ther 2010, 8:23–31.PubMedCrossRef De Bruyn G, Martinson N, Gray GE: Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Rev Anti Infect Ther 2010, 8:23–31.PubMedCrossRef
102.
go back to reference Doyle SM, Khan JG, Hosang N, Carroll PR: The impact of male circumcision on HIV transmission. J Urol 2010, 182:21–26.CrossRef Doyle SM, Khan JG, Hosang N, Carroll PR: The impact of male circumcision on HIV transmission. J Urol 2010, 182:21–26.CrossRef
104.
go back to reference Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007, 7:16.PubMedCrossRef Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC: Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007, 7:16.PubMedCrossRef
105.
106.
go back to reference Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC: Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002, 161:867–873.PubMedCrossRef Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC: Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002, 161:867–873.PubMedCrossRef
107.
go back to reference de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MAWP, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek1 TBH: Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367–371.PubMedCrossRef de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MAWP, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek1 TBH: Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367–371.PubMedCrossRef
108.
go back to reference Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, Thiounn N, Tomasini J, Wolf JP, Bomsel M: Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 2010, 3:506–522.PubMedCrossRef Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, Thiounn N, Tomasini J, Wolf JP, Bomsel M: Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 2010, 3:506–522.PubMedCrossRef
109.
go back to reference Ganor Y, Bomsel M: HIV-1 Transmission in the male genital tract. Am J Reprod Immunol 2011, 65:284–291.PubMedCrossRef Ganor Y, Bomsel M: HIV-1 Transmission in the male genital tract. Am J Reprod Immunol 2011, 65:284–291.PubMedCrossRef
110.
go back to reference Dinh MH, McRaven MD, Kelley ZL, Penugonda S, Hope TJ: Keratinization of the adult male foreskin and implications for male circumcision. AIDS 2010, 24:899–906.PubMedCrossRef Dinh MH, McRaven MD, Kelley ZL, Penugonda S, Hope TJ: Keratinization of the adult male foreskin and implications for male circumcision. AIDS 2010, 24:899–906.PubMedCrossRef
111.
go back to reference Qin Q, Zheng XY, Wang YY, Shen HF, Sun F, Ding W: Langerhans' cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. Int Urol Nephrol 2009, 41:747–753.PubMedCrossRef Qin Q, Zheng XY, Wang YY, Shen HF, Sun F, Ding W: Langerhans' cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. Int Urol Nephrol 2009, 41:747–753.PubMedCrossRef
112.
go back to reference Fischetti L, Barry SM, Hope TJ, Shattock RJ: HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 2009, 23:319–328.PubMedCrossRef Fischetti L, Barry SM, Hope TJ, Shattock RJ: HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 2009, 23:319–328.PubMedCrossRef
113.
go back to reference Dinh MH, Fahrbach KM, Hope TJ: The role of the foreskin in male circumcision: an evidence-based review. Am J Reprod Immunol 2010, 65:279–283.PubMedCrossRef Dinh MH, Fahrbach KM, Hope TJ: The role of the foreskin in male circumcision: an evidence-based review. Am J Reprod Immunol 2010, 65:279–283.PubMedCrossRef
114.
go back to reference Ministry of Health, National AIDS and STI Control Program: Kenya AIDS Indicator Survey 2007. Nairobi; 2008. Ministry of Health, National AIDS and STI Control Program: Kenya AIDS Indicator Survey 2007. Nairobi; 2008.
115.
go back to reference Gebremedhin S: Assessment of the Protective Effect of Male Circumcision from HIV Infection and Sexually Transmitted Diseases: Evidence from 18 Demographic and Health Surveys in Sub-Saharan Africa. Afr J Reprod Health 2010, 14:105–113.PubMed Gebremedhin S: Assessment of the Protective Effect of Male Circumcision from HIV Infection and Sexually Transmitted Diseases: Evidence from 18 Demographic and Health Surveys in Sub-Saharan Africa. Afr J Reprod Health 2010, 14:105–113.PubMed
116.
go back to reference Wamai RG, Weiss HA, Hankins C, Karim QA, Shisana O, Bailey RC, Betukumesu B, Bongaarts J, Bowa K, Cash R, Cates W, Diallo MO, Dludlu S, Geffen N, Heywood M, Jackson H, Kayembe PK, Kapiga S, Kebaabetswe P, Kintaudi L, Klausner JD, Leclerc-Madlala S, Mabuza K, Benjamin Makhubele M, Micheni K, Morris BJ, de Moya A, Ncala J, Ntaganira I, Nyamucherera OF, Otolorin EO, Pape JW, Phiri M, Rees H, Ruiz M, Sanchez J, Sawires S, Seloilwe ES, Serwadda DM, Setswe G, Sewankambo N, Simelane D, Venter F, Wilson D, Woelk G, Zungu N, Halperin DT: Male circumcision is an efficacious, lasting and cost-effective strategy for combating HIV in high-prevalence AIDS epidemics: time to move beyond debating the science. Fut HIV Ther 2008, 2:399–405.CrossRef Wamai RG, Weiss HA, Hankins C, Karim QA, Shisana O, Bailey RC, Betukumesu B, Bongaarts J, Bowa K, Cash R, Cates W, Diallo MO, Dludlu S, Geffen N, Heywood M, Jackson H, Kayembe PK, Kapiga S, Kebaabetswe P, Kintaudi L, Klausner JD, Leclerc-Madlala S, Mabuza K, Benjamin Makhubele M, Micheni K, Morris BJ, de Moya A, Ncala J, Ntaganira I, Nyamucherera OF, Otolorin EO, Pape JW, Phiri M, Rees H, Ruiz M, Sanchez J, Sawires S, Seloilwe ES, Serwadda DM, Setswe G, Sewankambo N, Simelane D, Venter F, Wilson D, Woelk G, Zungu N, Halperin DT: Male circumcision is an efficacious, lasting and cost-effective strategy for combating HIV in high-prevalence AIDS epidemics: time to move beyond debating the science. Fut HIV Ther 2008, 2:399–405.CrossRef
117.
go back to reference Gersovitz M: The HIV epidemic in four African countries seen through the demographic and health surveys. J Afr Econ 2005, 14:191–246.CrossRef Gersovitz M: The HIV epidemic in four African countries seen through the demographic and health surveys. J Afr Econ 2005, 14:191–246.CrossRef
119.
go back to reference Lowndes CM, Alary M, Belleau M, Bosu WK, Kintin DF, Nnorom JA, Seck K, Victor-Ahuchogu J, Wilson D: West Africa HIV/AIDS epidemiology and response synthesis: implications for prevention. Washington, DC: World Bank; 2008. Lowndes CM, Alary M, Belleau M, Bosu WK, Kintin DF, Nnorom JA, Seck K, Victor-Ahuchogu J, Wilson D: West Africa HIV/AIDS epidemiology and response synthesis: implications for prevention. Washington, DC: World Bank; 2008.
120.
go back to reference Piot P, Greener R, Russell S: Squaring the circle: AIDS, poverty, and human development. PLoS Med 2007, 4:e314.CrossRef Piot P, Greener R, Russell S: Squaring the circle: AIDS, poverty, and human development. PLoS Med 2007, 4:e314.CrossRef
121.
go back to reference Brewer DD, Potterat JJ, Roberts JM, Brody S: Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania. Ann Epidemiol 2007, 17:217–226.PubMed Brewer DD, Potterat JJ, Roberts JM, Brody S: Male and female circumcision associated with prevalent HIV infection in virgins and adolescents in Kenya, Lesotho, and Tanzania. Ann Epidemiol 2007, 17:217–226.PubMed
122.
go back to reference Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Ngole EM, Bienvenue Y, Delaporte E, Brookfield JFY, Sharp PM, Shaw GM, Peeters M, Hahn BH: Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006, 313:523–526.PubMedCrossRef Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Ngole EM, Bienvenue Y, Delaporte E, Brookfield JFY, Sharp PM, Shaw GM, Peeters M, Hahn BH: Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006, 313:523–526.PubMedCrossRef
123.
go back to reference Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM: Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003, 100:6588–6592.PubMedCrossRef Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM: Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003, 100:6588–6592.PubMedCrossRef
124.
go back to reference Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ: HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:770–777.PubMedCrossRef Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ: HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:770–777.PubMedCrossRef
125.
go back to reference Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006, 3:e517.PubMedCrossRef Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006, 3:e517.PubMedCrossRef
126.
go back to reference Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M: The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007, 21:845–850.PubMedCrossRef Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M: The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007, 21:845–850.PubMedCrossRef
127.
go back to reference Londish GJ, Murray JM: Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol 2008, 37:1246–1253.PubMedCrossRef Londish GJ, Murray JM: Significant reduction in HIV prevalence according to male circumcision intervention in sub-Saharan Africa. Int J Epidemiol 2008, 37:1246–1253.PubMedCrossRef
128.
go back to reference Galarraga O, Colchero A, Wamai RG, Bertozzi SM: HIV Prevention Cost-Effectiveness: A Systematic Review. BMC Public Health 2009,9(Suppl 1):S5.PubMed Galarraga O, Colchero A, Wamai RG, Bertozzi SM: HIV Prevention Cost-Effectiveness: A Systematic Review. BMC Public Health 2009,9(Suppl 1):S5.PubMed
129.
go back to reference Uthman OA, Popoola TA, Uthman MMB, Olatunde A: Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review. PLoS One 2010, 5:e9628.PubMedCrossRef Uthman OA, Popoola TA, Uthman MMB, Olatunde A: Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review. PLoS One 2010, 5:e9628.PubMedCrossRef
130.
go back to reference UNAIDS/WHO/SACEMA Expert Group on Modeling the Impact and Cost of Male Circumcision for HIV Prevention: Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modeling contribute to informed decision making? PLoS Med 2009, 6:e1000109.CrossRef UNAIDS/WHO/SACEMA Expert Group on Modeling the Impact and Cost of Male Circumcision for HIV Prevention: Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modeling contribute to informed decision making? PLoS Med 2009, 6:e1000109.CrossRef
133.
go back to reference Binagwaho A, Pegurri E, Muita J, Bertozzi S: Male circumcision at different ages in Rwanda: a cost-effectiveness study. PLoS Med 2010, 7:e1000211.PubMedCrossRef Binagwaho A, Pegurri E, Muita J, Bertozzi S: Male circumcision at different ages in Rwanda: a cost-effectiveness study. PLoS Med 2010, 7:e1000211.PubMedCrossRef
134.
go back to reference Sansom SL, Prabhu VS, Hutchinson AB, An Q, Hall HI, Shrestha RK, Lasry A, Taylor AW: Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One 2010, 5:e8723.PubMedCrossRef Sansom SL, Prabhu VS, Hutchinson AB, An Q, Hall HI, Shrestha RK, Lasry A, Taylor AW: Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One 2010, 5:e8723.PubMedCrossRef
135.
go back to reference White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, Weiss HA, Kumaranayake L, Habbema JD, Buvé A, Hayes RJ: Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS 2008, 22:1841–1850.PubMedCrossRef White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, Weiss HA, Kumaranayake L, Habbema JD, Buvé A, Hayes RJ: Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS 2008, 22:1841–1850.PubMedCrossRef
136.
go back to reference Hallett TB, Alsallaq RA, Baeten JM, Weiss H, Celum C, Gray R, Abu-Raddad L: Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect 2011, 87:88–93.PubMedCrossRef Hallett TB, Alsallaq RA, Baeten JM, Weiss H, Celum C, Gray R, Abu-Raddad L: Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect 2011, 87:88–93.PubMedCrossRef
137.
go back to reference Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, Buwembo D, Ssempijja V, Kiwanuka N, Moulton LH, Sewankambo NK, Reynolds SJ, Quinn TC, Opendi P, Iga B, Ridzon R, Laeyendecker O, Gray RH: Circumcision in HIV-infected men and its eff ect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 2009, 374:229–237.PubMedCrossRef Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, Buwembo D, Ssempijja V, Kiwanuka N, Moulton LH, Sewankambo NK, Reynolds SJ, Quinn TC, Opendi P, Iga B, Ridzon R, Laeyendecker O, Gray RH: Circumcision in HIV-infected men and its eff ect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 2009, 374:229–237.PubMedCrossRef
138.
go back to reference Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C, Partners in Prevention HSV/HIV Transmission Study Team: Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS 2010, 24:737–744.PubMedCrossRef Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C, Partners in Prevention HSV/HIV Transmission Study Team: Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS 2010, 24:737–744.PubMedCrossRef
139.
go back to reference Centre for HIV/AIDS Prevention Studies: Women and MMC: interview with Prof Bertran Auvert. Centre for HIV/AIDS Prevention Studies; 2011. Centre for HIV/AIDS Prevention Studies: Women and MMC: interview with Prof Bertran Auvert. Centre for HIV/AIDS Prevention Studies; 2011.
140.
go back to reference Schoen EJ, Oehrli M, Colby CJ, Machin G: The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000, 105:e36.PubMedCrossRef Schoen EJ, Oehrli M, Colby CJ, Machin G: The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 2000, 105:e36.PubMedCrossRef
142.
go back to reference Weiss GN: Prophylactic neonatal surgery and infectious diseases. Pediat Infect Dis J 1997, 16:727–734.CrossRef Weiss GN: Prophylactic neonatal surgery and infectious diseases. Pediat Infect Dis J 1997, 16:727–734.CrossRef
143.
go back to reference Tobian AA, Gray RH, Quinn TC: Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med 2010, 164:78–84.PubMedCrossRef Tobian AA, Gray RH, Quinn TC: Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med 2010, 164:78–84.PubMedCrossRef
145.
go back to reference MacNeily AE, Afshar K: Circumcision and non-HIV sexually transmitted infections. Can Urol Assoc J 2011, 5:58–59.PubMedCrossRef MacNeily AE, Afshar K: Circumcision and non-HIV sexually transmitted infections. Can Urol Assoc J 2011, 5:58–59.PubMedCrossRef
146.
go back to reference Morris BJ, Gray RH, Castellsague X, Bosch FX, Halperin DT, Waskett JH, Hankins CA: The strong protective effect of circumcision against cancer of the penis. Adv Urol 2011, 1–21. Article ID 812368 Morris BJ, Gray RH, Castellsague X, Bosch FX, Halperin DT, Waskett JH, Hankins CA: The strong protective effect of circumcision against cancer of the penis. Adv Urol 2011, 1–21. Article ID 812368
147.
go back to reference Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, Charvat B, Ssempijja V, Riedesel M, Oliver AE, Nowak RG, Moulton LH, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH: Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009, 360:1298–1309.PubMedCrossRef Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, Charvat B, Ssempijja V, Riedesel M, Oliver AE, Nowak RG, Moulton LH, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH: Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009, 360:1298–1309.PubMedCrossRef
148.
go back to reference Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, Moulton L, Chen MZ, Sewankambo NK, Kiwanuka N, Sempijja V, Lutalo T, Kagayii J, Wabwire-Mangen F, Ridzon R, Bacon M, Wawer MJ: The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009, 200:42.e1–42.e7.CrossRef Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, Moulton L, Chen MZ, Sewankambo NK, Kiwanuka N, Sempijja V, Lutalo T, Kagayii J, Wabwire-Mangen F, Ridzon R, Bacon M, Wawer MJ: The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009, 200:42.e1–42.e7.CrossRef
149.
go back to reference Tarnaud C, Lissouba P, Cutler E, Puren A, Taljaard D, Auvert B: Association of low-risk human papillomavirus infection with male circumcision in young men: results from a longitudinal study conducted in orange farm (South Africa). Infect Dis Obstet Gynecol 2011, 2011:567408.PubMed Tarnaud C, Lissouba P, Cutler E, Puren A, Taljaard D, Auvert B: Association of low-risk human papillomavirus infection with male circumcision in young men: results from a longitudinal study conducted in orange farm (South Africa). Infect Dis Obstet Gynecol 2011, 2011:567408.PubMed
150.
go back to reference Lane T, Raymond HF, Dladla S, Rasethe J, Struthers H, McFarland W, McIntyre J: High HIV prevalence among men who have sex with men in Soweto, South Africa: Results from the Soweto Men's Study. AIDS Behav 2011, 15:626–634.PubMedCrossRef Lane T, Raymond HF, Dladla S, Rasethe J, Struthers H, McFarland W, McIntyre J: High HIV prevalence among men who have sex with men in Soweto, South Africa: Results from the Soweto Men's Study. AIDS Behav 2011, 15:626–634.PubMedCrossRef
151.
go back to reference Millett GA, Flores SA, Marks G, Reed JB, Herbst JH: Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008, 300:1674–1684.PubMedCrossRef Millett GA, Flores SA, Marks G, Reed JB, Herbst JH: Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008, 300:1674–1684.PubMedCrossRef
152.
go back to reference Wiysonge CS, Kongnyuy EJ, Shey M, Muula AS, Navti OB, Akl EA, Lo YR: Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Syst Rev 2011, 6:CD007496.PubMed Wiysonge CS, Kongnyuy EJ, Shey M, Muula AS, Navti OB, Akl EA, Lo YR: Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Syst Rev 2011, 6:CD007496.PubMed
153.
go back to reference Schneider JA, Michaels S, Gandham SR, McFadden R, Liao C, Yeldandi VV, Oruganti G: A protective effect of circumcision among receptive male sex partners of Indian men who have sex with men. AIDS Behav 2011, in press. Schneider JA, Michaels S, Gandham SR, McFadden R, Liao C, Yeldandi VV, Oruganti G: A protective effect of circumcision among receptive male sex partners of Indian men who have sex with men. AIDS Behav 2011, in press.
154.
go back to reference Rennie S, Muula AS, Westreich D: MC and HIV prevention - ethical, medical and public health tradeoffs in low-income countries. J Med Ethics 2007, 33:357–361.PubMedCrossRef Rennie S, Muula AS, Westreich D: MC and HIV prevention - ethical, medical and public health tradeoffs in low-income countries. J Med Ethics 2007, 33:357–361.PubMedCrossRef
155.
go back to reference Mehta SD, Gray RH, Auvert B, Moses S, Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC: Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS 2009, 23:1557–1564.PubMedCrossRef Mehta SD, Gray RH, Auvert B, Moses S, Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC: Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS 2009, 23:1557–1564.PubMedCrossRef
156.
go back to reference Cooper DA, Wodak AD, Morris BJ: The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV. Med J Aust 2010, 193:318–319.PubMed Cooper DA, Wodak AD, Morris BJ: The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV. Med J Aust 2010, 193:318–319.PubMed
157.
go back to reference Green LW, Travis JW, McAllister RG, Peterson KW, Vardanyan AN, Craig A: Male circumcision and HIV prevention insufficient evidence and neglected external validity. Am J Prev Med 2010, 39:479–482.PubMedCrossRef Green LW, Travis JW, McAllister RG, Peterson KW, Vardanyan AN, Craig A: Male circumcision and HIV prevention insufficient evidence and neglected external validity. Am J Prev Med 2010, 39:479–482.PubMedCrossRef
158.
go back to reference Banerjee J, Klausner JD, Halperin DT, Wamai R, Schoen EJ, Moses S, Morris BJ, Bailis SA, Venter F, Martinson N, Coates TJ, Gray G, Bowa K: Circumcision Denialism Unfounded and Unscientific. Am J Prev Med 2011, 40:e11-e12.PubMedCrossRef Banerjee J, Klausner JD, Halperin DT, Wamai R, Schoen EJ, Moses S, Morris BJ, Bailis SA, Venter F, Martinson N, Coates TJ, Gray G, Bowa K: Circumcision Denialism Unfounded and Unscientific. Am J Prev Med 2011, 40:e11-e12.PubMedCrossRef
159.
go back to reference Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, Weiss NS: Male circumcision in Siaya and Bondo districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr 2007, 44:66–70.PubMedCrossRef Agot KE, Kiarie JN, Nguyen HQ, Odhiambo JO, Onyango TM, Weiss NS: Male circumcision in Siaya and Bondo districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr 2007, 44:66–70.PubMedCrossRef
160.
go back to reference Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, Moses S: Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One 2008, 3:e2443.PubMedCrossRef Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, Moses S: Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One 2008, 3:e2443.PubMedCrossRef
161.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Ndinya-Achola JO: The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial. XVII International AIDS Conference 2008. Abstract #THAC05 Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Ndinya-Achola JO: The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial. XVII International AIDS Conference 2008. Abstract #THAC05
162.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, MacLean I, Krieger JN, Williams CFM, Ndinya-Achola JO: The protective effect of adult male circumcision against HIV acquisition is sustained for at least 54 months: results from the Kisumu, Kenya trial. In XVIII International AIDS Conference, Jul 18–23, 2010. Vienna; 2010. Abstract #FRLBC1 Bailey RC, Moses S, Parker CB, Agot K, MacLean I, Krieger JN, Williams CFM, Ndinya-Achola JO: The protective effect of adult male circumcision against HIV acquisition is sustained for at least 54 months: results from the Kisumu, Kenya trial. In XVIII International AIDS Conference, Jul 18–23, 2010. Vienna; 2010. Abstract #FRLBC1
163.
go back to reference Kong X, Kigozi G, Ssempija V, Serwadda D, Nalugoda F, Makumbi F, Lutalo T, Watya S, Wawer M, R Gray R: Longer-term effects of male circumcision on HIV incidence and risk behaviors during post-trial surveillance in Rakai, Uganda. 18th Conference on Retroviruses and Opportunistic Infections, Boston 2011. Abstract #36 Kong X, Kigozi G, Ssempija V, Serwadda D, Nalugoda F, Makumbi F, Lutalo T, Watya S, Wawer M, R Gray R: Longer-term effects of male circumcision on HIV incidence and risk behaviors during post-trial surveillance in Rakai, Uganda. 18th Conference on Retroviruses and Opportunistic Infections, Boston 2011. Abstract #36
164.
go back to reference Herman-Roloff A, Llewellyn E, Obiero W, Agot K, Ndinya-Achola J, Muraguri N, Bailey RC: Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: Lessons learned during the first year. PLoS ONE 2011, 6:e18299.PubMedCrossRef Herman-Roloff A, Llewellyn E, Obiero W, Agot K, Ndinya-Achola J, Muraguri N, Bailey RC: Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: Lessons learned during the first year. PLoS ONE 2011, 6:e18299.PubMedCrossRef
166.
go back to reference Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J: Reassessing HIV prevention. Science 2008, 320:749–750.PubMedCrossRef Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J: Reassessing HIV prevention. Science 2008, 320:749–750.PubMedCrossRef
168.
go back to reference Gebbie KM: Science and policy: a perpetual dilemma. AIDS Reader 2009, 19:100–101.PubMed Gebbie KM: Science and policy: a perpetual dilemma. AIDS Reader 2009, 19:100–101.PubMed
171.
go back to reference Dickson K, Farley T: Male circumcision scale-up. 17th Conference on Retroviruses and Opportunistic Infections (CROI); 2010. San Francisco. Abstract oral#62 Dickson K, Farley T: Male circumcision scale-up. 17th Conference on Retroviruses and Opportunistic Infections (CROI); 2010. San Francisco. Abstract oral#62
175.
go back to reference WHO: Task Shifting: Rational Redistribution of Tasks Among Health Workforce Teams: Global Recommendations and Guidelines. Geneva; 2008. WHO: Task Shifting: Rational Redistribution of Tasks Among Health Workforce Teams: Global Recommendations and Guidelines. Geneva; 2008.
177.
go back to reference Wambura M, Mwanga JR, Mosha JF, Mshana G, Mosha F, Changalucha J: Acceptability of medical male circumcision in the traditionally circumcising communities in Northern Tanzania. BMC Public Health 2011, 11:373.PubMedCrossRef Wambura M, Mwanga JR, Mosha JF, Mshana G, Mosha F, Changalucha J: Acceptability of medical male circumcision in the traditionally circumcising communities in Northern Tanzania. BMC Public Health 2011, 11:373.PubMedCrossRef
178.
go back to reference Morris BJ, Eley C: Male circumcision: An appraisal of current instrumentation. In: Biomedical Engineering. In Biomedical Engineering - From Theory to Applications Edited by: Fazel-Rezai R. 2011. InTech Morris BJ, Eley C: Male circumcision: An appraisal of current instrumentation. In: Biomedical Engineering. In Biomedical Engineering - From Theory to Applications Edited by: Fazel-Rezai R. 2011. InTech
179.
go back to reference Masson P, Li PS, Barone MA, Goldstein M: The ShangRing device for simplified adult circumcision. Nat Rev Urol 2010, 7:638–642.PubMedCrossRef Masson P, Li PS, Barone MA, Goldstein M: The ShangRing device for simplified adult circumcision. Nat Rev Urol 2010, 7:638–642.PubMedCrossRef
180.
go back to reference Barone MA, Ndede F, Li PS, Masson P, Awori Q, Okech J, Cherutich P, Muraguri N, Perchal P, Lee R, Kim HH, Goldstein M: The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr 2011, 57:e7-e12.PubMedCrossRef Barone MA, Ndede F, Li PS, Masson P, Awori Q, Okech J, Cherutich P, Muraguri N, Perchal P, Lee R, Kim HH, Goldstein M: The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr 2011, 57:e7-e12.PubMedCrossRef
181.
go back to reference Decastro B, Gurski J, Peterson A: Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device. Urology 2010, 76:810–814.PubMedCrossRef Decastro B, Gurski J, Peterson A: Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device. Urology 2010, 76:810–814.PubMedCrossRef
182.
go back to reference Bitega JP, Ngeruka ML, Hategekimana T, Asiimwe A, Binagwaho A: Safety and efficacy study of the PrePex system for male circumcision. 18th Conference on Retroviruses and Opportunistic Infections, Boston; 2011. Abstract #1007 Bitega JP, Ngeruka ML, Hategekimana T, Asiimwe A, Binagwaho A: Safety and efficacy study of the PrePex system for male circumcision. 18th Conference on Retroviruses and Opportunistic Infections, Boston; 2011. Abstract #1007
183.
go back to reference Peng Y-F, Cheng Y, Wang GY, Wang SQ, Jia C, Yang BH, Zhu R, Jian SC, Li QW, Geng DW: Clinical application of a new device for minimally invasive circumcision. Asian J Androl 2008, 10:447–454.PubMedCrossRef Peng Y-F, Cheng Y, Wang GY, Wang SQ, Jia C, Yang BH, Zhu R, Jian SC, Li QW, Geng DW: Clinical application of a new device for minimally invasive circumcision. Asian J Androl 2008, 10:447–454.PubMedCrossRef
184.
go back to reference Lagarde E, Taljaard D, Puren A, Auvert B: High rate of adverse events consecutive to circumcision of young male adults with the Tara KLamp technique. Results from a randomized trial conducted in South Africa. S Afr Med J 2009, 99:163–169.PubMed Lagarde E, Taljaard D, Puren A, Auvert B: High rate of adverse events consecutive to circumcision of young male adults with the Tara KLamp technique. Results from a randomized trial conducted in South Africa. S Afr Med J 2009, 99:163–169.PubMed
189.
go back to reference Smith DK, Taylor A, Kilmarx PH, Sullivan P, Warner L, Kamb M, Bock N, Kohmescher B, Mastro TD: Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep 2010,125(Suppl 1):72–82.PubMed Smith DK, Taylor A, Kilmarx PH, Sullivan P, Warner L, Kamb M, Bock N, Kohmescher B, Mastro TD: Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Rep 2010,125(Suppl 1):72–82.PubMed
190.
go back to reference Xu F, Markowitz LE, Sternberg MR, Aral SO: Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: The National Health and Nutrition Examination Survey (NHANES), 1999–2004. Sex Transm Dis 2007, 34:479–484.PubMed Xu F, Markowitz LE, Sternberg MR, Aral SO: Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: The National Health and Nutrition Examination Survey (NHANES), 1999–2004. Sex Transm Dis 2007, 34:479–484.PubMed
191.
go back to reference McKinney CM, Klingler EJ, Paneth-Pollak R, Schillinger JA, Gwynn RC, Frieden TR: Prevalence of adult male circumcision in the general population and a population at increased risk for HIV/AIDS in New York City. Sex Transm Dis 2008, 35:814–817.PubMedCrossRef McKinney CM, Klingler EJ, Paneth-Pollak R, Schillinger JA, Gwynn RC, Frieden TR: Prevalence of adult male circumcision in the general population and a population at increased risk for HIV/AIDS in New York City. Sex Transm Dis 2008, 35:814–817.PubMedCrossRef
192.
go back to reference Sutton MY, Jones RL, Wolitski RJ, Cleveland JC, Dean HD, Fenton KA: A review of the Centers for Disease Control and Prevention's response to the HIV/AIDS crisis among Blacks in the United States, 1981–2009. Am J Public Health 2009,99(Suppl 2):S351-S359.PubMedCrossRef Sutton MY, Jones RL, Wolitski RJ, Cleveland JC, Dean HD, Fenton KA: A review of the Centers for Disease Control and Prevention's response to the HIV/AIDS crisis among Blacks in the United States, 1981–2009. Am J Public Health 2009,99(Suppl 2):S351-S359.PubMedCrossRef
193.
go back to reference Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, HIV Incidence Surveillance Group: Estimation of HIV incidence in the United States. JAMA 2008, 300:520–529.PubMedCrossRef Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, HIV Incidence Surveillance Group: Estimation of HIV incidence in the United States. JAMA 2008, 300:520–529.PubMedCrossRef
194.
go back to reference Centers for Disease Control and Prevention: Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004–2007. MMWR 2010, 59:97–101. Centers for Disease Control and Prevention: Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004–2007. MMWR 2010, 59:97–101.
195.
go back to reference Centers for Disease Control and Prevention: Racial/ethnic disparities in diagnoses of HIV/AIDS -- 33 states, 2001–2005. MMWR 2007, 56:189–193. Centers for Disease Control and Prevention: Racial/ethnic disparities in diagnoses of HIV/AIDS -- 33 states, 2001–2005. MMWR 2007, 56:189–193.
196.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, iPrEx Study Team: Preexposure Chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010, 363:2587–2599.PubMedCrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, iPrEx Study Team: Preexposure Chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010, 363:2587–2599.PubMedCrossRef
197.
go back to reference Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, CAPRISA 004 Trial Group: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168–1174.PubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, CAPRISA 004 Trial Group: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168–1174.PubMedCrossRef
198.
go back to reference Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, MOPH-TAVEG Investigators: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med 2009, 361:2209–2220.PubMedCrossRef Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, MOPH-TAVEG Investigators: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Engl J Med 2009, 361:2209–2220.PubMedCrossRef
199.
go back to reference Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, Lutalo T, Kiwanuka N, Kigozi G, Nalugoda F, Meehan MP, Ashley Morrow R, Wawer MJ: Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003, 188:1492–1497.PubMedCrossRef Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, Lutalo T, Kiwanuka N, Kigozi G, Nalugoda F, Meehan MP, Ashley Morrow R, Wawer MJ: Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003, 188:1492–1497.PubMedCrossRef
200.
go back to reference Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004, 35:435–445.PubMedCrossRef Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004, 35:435–445.PubMedCrossRef
Metadata
Title
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa
Authors
Richard G Wamai
Brian J Morris
Stefan A Bailis
David Sokal
Jeffrey D Klausner
Ross Appleton
Nelson Sewankambo
David A Cooper
John Bongaarts
Guy de Bruyn
Alex D Wodak
Joya Banerjee
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2011
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-14-49

Other articles of this Issue 1/2011

Journal of the International AIDS Society 1/2011 Go to the issue